XEUM:LSE:LSE-db x-trackers MSCI Europe Mid Cap UCITS DR 1C (GBX)

ETF | Others |

Last Closing

USD 13842

Change

+90.00 (+0.65)%

Market Cap

N/A

Volume

24.00

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-13 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XNID:LSE Xtrackers Nifty 50 Swap UCITS ..

+1.61 (+0.59%)

USD 292,109.69B
0R1O:LSE Amazon.com Inc.

+2.00 (+1.02%)

USD 1,607.29B
0R1I:LSE NVIDIA Corp.

+0.33 (+0.24%)

USD 618.20B
LCJP:LSE Lyxor Core MSCI Japan (DR) UCI..

+0.05 (+0.38%)

USD 584.80B
LCJD:LSE Amundi MSCI Japan (DR) UCITS E..

+0.14 (+0.80%)

USD 583.82B
0R1G:LSE Home Depot Inc.

N/A

USD 373.16B
0QZK:LSE Coca-Cola Co.

+0.25 (+0.39%)

USD 266.08B
0QZO:LSE 0QZO

+1.15 (+1.21%)

USD 258.54B
PRJU:LSE Amundi Index Solutions - Amund..

+0.19 (+0.65%)

USD 204.07B
0QZ3:LSE Qualcomm Inc.

N/A

USD 202.26B

ETFs Containing XEUM:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 6.57% 56% F 58% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 6.57% 55% F 57% F
Trailing 12 Months  
Capital Gain 12.55% 59% D- 60% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 12.55% 57% F 59% D-
Trailing 5 Years  
Capital Gain 49.34% 70% C- 74% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 49.34% 68% D+ 72% C
Average Annual (5 Year Horizon)  
Capital Gain 10.98% 70% C- 72% C
Dividend Return 10.98% 69% C- 71% C-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 12.88% 53% F 70% C-
Risk Adjusted Return 85.22% 88% B+ 92% A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (GBX)

Quarterly Financials (GBX)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike